Sparsentan
CAS 254740-64-2
In Stock
Sparsentan
Cat. No. STUB-API-SPARSENTANCAS 254740-64-2In Stock
Technical Data
Cat. No.STUB-API-SPARSENTAN
CAS254740-64-2
Mol. FormulaC32H40N4O5S
Mol. Weight592.762 g/mol
IUPAC2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamide
SMILESCCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC5=NOC(=C5C)C)COCC
InChIInChI=1S/C32H40N4O5S/c1-5-7-14-29-33-32(17-10-11-18-32)31(37)36(29)20-24-15-16-26(25(19-24)21-40-6-2)27-12-8-9-13-28(27)42(38,39)35-30-22(3)23(4)41-34-30/h8-9,12-13,15-16,19H,5-7,10-11,14,17-18,20-21H2,1-4H3,(H,34,35)
InChI KeyWRFHGDPIDHPWIQ-UHFFFAOYSA-N
Purity—
Description
Overview
Sparsentan is an FDA-approved medication used to treat primary immunoglobulin A nephropathy (IgAN) to help maintain kidney function and reduce protein in urine (proteinuria)
Anant Labs manufacture and furnish high quality Sparsentan impurities for global markets. Our Sparsentan EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
sparsentan254740-64-2RE-021FILSPARIPS433540esparsentanPS-433540sparsentanum9242RO5URM(1,1'-Biphenyl)-2-sulfonamide, 4'-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-
